nodes	percent_of_prediction	percent_of_DWPC	metapath
Penicillamine—rheumatoid arthritis—systemic lupus erythematosus	0.682	1	CtDrD
Penicillamine—SLCO1B1—Mycophenolate mofetil—systemic lupus erythematosus	0.0992	0.463	CbGbCtD
Penicillamine—SLCO1B1—Cyclosporine—systemic lupus erythematosus	0.0752	0.351	CbGbCtD
Penicillamine—SLCO1B1—Methotrexate—systemic lupus erythematosus	0.0398	0.186	CbGbCtD
Penicillamine—Injury—Prednisone—systemic lupus erythematosus	0.000135	0.0013	CcSEcCtD
Penicillamine—Haematuria—Mycophenolate mofetil—systemic lupus erythematosus	0.000135	0.00129	CcSEcCtD
Penicillamine—Aplastic anaemia—Methotrexate—systemic lupus erythematosus	0.000134	0.00129	CcSEcCtD
Penicillamine—Hepatobiliary disease—Mycophenolate mofetil—systemic lupus erythematosus	0.000133	0.00128	CcSEcCtD
Penicillamine—Pancreatitis—Triamcinolone—systemic lupus erythematosus	0.000133	0.00128	CcSEcCtD
Penicillamine—Nausea—Dapsone—systemic lupus erythematosus	0.000133	0.00128	CcSEcCtD
Penicillamine—Pancreatitis—Methylprednisolone—systemic lupus erythematosus	0.000133	0.00128	CcSEcCtD
Penicillamine—Arthralgia—Azathioprine—systemic lupus erythematosus	0.000132	0.00127	CcSEcCtD
Penicillamine—Agranulocytosis—Mycophenolate mofetil—systemic lupus erythematosus	0.000132	0.00127	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—systemic lupus erythematosus	0.000131	0.00126	CcSEcCtD
Penicillamine—Leukopenia—Leflunomide—systemic lupus erythematosus	0.000131	0.00126	CcSEcCtD
Penicillamine—Haemoglobin—Cyclosporine—systemic lupus erythematosus	0.000131	0.00125	CcSEcCtD
Penicillamine—Haemorrhage—Cyclosporine—systemic lupus erythematosus	0.00013	0.00125	CcSEcCtD
Penicillamine—Mouth ulceration—Methotrexate—systemic lupus erythematosus	0.000129	0.00124	CcSEcCtD
Penicillamine—Neuropathy peripheral—Prednisolone—systemic lupus erythematosus	0.000129	0.00124	CcSEcCtD
Penicillamine—Urinary tract disorder—Cyclosporine—systemic lupus erythematosus	0.000128	0.00123	CcSEcCtD
Penicillamine—Haemoglobin—Mycophenolate mofetil—systemic lupus erythematosus	0.000127	0.00122	CcSEcCtD
Penicillamine—Urethral disorder—Cyclosporine—systemic lupus erythematosus	0.000127	0.00122	CcSEcCtD
Penicillamine—Haemorrhage—Mycophenolate mofetil—systemic lupus erythematosus	0.000127	0.00122	CcSEcCtD
Penicillamine—Neuropathy peripheral—Hydrocortisone—systemic lupus erythematosus	0.000126	0.00121	CcSEcCtD
Penicillamine—Muscular weakness—Betamethasone—systemic lupus erythematosus	0.000126	0.00121	CcSEcCtD
Penicillamine—Muscular weakness—Dexamethasone—systemic lupus erythematosus	0.000126	0.00121	CcSEcCtD
Penicillamine—Urinary tract disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000125	0.0012	CcSEcCtD
Penicillamine—Arthralgia—Leflunomide—systemic lupus erythematosus	0.000125	0.0012	CcSEcCtD
Penicillamine—Anxiety—Leflunomide—systemic lupus erythematosus	0.000124	0.00119	CcSEcCtD
Penicillamine—Urethral disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000124	0.00119	CcSEcCtD
Penicillamine—Thrombocytopenia—Azathioprine—systemic lupus erythematosus	0.000124	0.00119	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Leflunomide—systemic lupus erythematosus	0.000124	0.00119	CcSEcCtD
Penicillamine—Skin disorder—Azathioprine—systemic lupus erythematosus	0.000123	0.00118	CcSEcCtD
Penicillamine—Lymphadenopathy—Methotrexate—systemic lupus erythematosus	0.000122	0.00117	CcSEcCtD
Penicillamine—Tinnitus—Cyclosporine—systemic lupus erythematosus	0.000121	0.00116	CcSEcCtD
Penicillamine—Thrombophlebitis—Methotrexate—systemic lupus erythematosus	0.00012	0.00115	CcSEcCtD
Penicillamine—Haemoglobin—Prednisolone—systemic lupus erythematosus	0.000119	0.00114	CcSEcCtD
Penicillamine—Neuropathy peripheral—Triamcinolone—systemic lupus erythematosus	0.000119	0.00114	CcSEcCtD
Penicillamine—Neuropathy peripheral—Methylprednisolone—systemic lupus erythematosus	0.000118	0.00114	CcSEcCtD
Penicillamine—Haemorrhage—Prednisolone—systemic lupus erythematosus	0.000118	0.00114	CcSEcCtD
Penicillamine—Tinnitus—Mycophenolate mofetil—systemic lupus erythematosus	0.000118	0.00113	CcSEcCtD
Penicillamine—Angiopathy—Cyclosporine—systemic lupus erythematosus	0.000118	0.00113	CcSEcCtD
Penicillamine—Thrombocytopenia—Leflunomide—systemic lupus erythematosus	0.000117	0.00112	CcSEcCtD
Penicillamine—Skin disorder—Leflunomide—systemic lupus erythematosus	0.000116	0.00112	CcSEcCtD
Penicillamine—Haemoglobin—Hydrocortisone—systemic lupus erythematosus	0.000116	0.00111	CcSEcCtD
Penicillamine—Hepatic failure—Methotrexate—systemic lupus erythematosus	0.000115	0.00111	CcSEcCtD
Penicillamine—Haemorrhage—Hydrocortisone—systemic lupus erythematosus	0.000115	0.00111	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Azathioprine—systemic lupus erythematosus	0.000115	0.00111	CcSEcCtD
Penicillamine—Angiopathy—Mycophenolate mofetil—systemic lupus erythematosus	0.000115	0.0011	CcSEcCtD
Penicillamine—Alopecia—Cyclosporine—systemic lupus erythematosus	0.000115	0.0011	CcSEcCtD
Penicillamine—Anorexia—Leflunomide—systemic lupus erythematosus	0.000114	0.00109	CcSEcCtD
Penicillamine—Mental disorder—Cyclosporine—systemic lupus erythematosus	0.000114	0.00109	CcSEcCtD
Penicillamine—Alopecia—Mycophenolate mofetil—systemic lupus erythematosus	0.000112	0.00108	CcSEcCtD
Penicillamine—Mental disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000111	0.00107	CcSEcCtD
Penicillamine—Dysgeusia—Cyclosporine—systemic lupus erythematosus	0.000111	0.00106	CcSEcCtD
Penicillamine—Dermatitis exfoliative—Methotrexate—systemic lupus erythematosus	0.00011	0.00106	CcSEcCtD
Penicillamine—Muscular weakness—Prednisone—systemic lupus erythematosus	0.000109	0.00105	CcSEcCtD
Penicillamine—Haemoglobin—Triamcinolone—systemic lupus erythematosus	0.000109	0.00105	CcSEcCtD
Penicillamine—Haemoglobin—Methylprednisolone—systemic lupus erythematosus	0.000109	0.00105	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Leflunomide—systemic lupus erythematosus	0.000109	0.00105	CcSEcCtD
Penicillamine—Haemorrhage—Triamcinolone—systemic lupus erythematosus	0.000109	0.00104	CcSEcCtD
Penicillamine—Haemorrhage—Methylprednisolone—systemic lupus erythematosus	0.000108	0.00104	CcSEcCtD
Penicillamine—Dysgeusia—Mycophenolate mofetil—systemic lupus erythematosus	0.000108	0.00104	CcSEcCtD
Penicillamine—Neuropathy peripheral—Dexamethasone—systemic lupus erythematosus	0.000108	0.00103	CcSEcCtD
Penicillamine—Neuropathy peripheral—Betamethasone—systemic lupus erythematosus	0.000108	0.00103	CcSEcCtD
Penicillamine—Pancreatitis—Prednisone—systemic lupus erythematosus	0.000105	0.00101	CcSEcCtD
Penicillamine—Anaemia—Cyclosporine—systemic lupus erythematosus	0.000104	0.001	CcSEcCtD
Penicillamine—Decreased appetite—Leflunomide—systemic lupus erythematosus	0.000104	0.000998	CcSEcCtD
Penicillamine—Agitation—Cyclosporine—systemic lupus erythematosus	0.000104	0.000998	CcSEcCtD
Penicillamine—Anaemia—Mycophenolate mofetil—systemic lupus erythematosus	0.000102	0.000979	CcSEcCtD
Penicillamine—Agitation—Mycophenolate mofetil—systemic lupus erythematosus	0.000101	0.000974	CcSEcCtD
Penicillamine—Leukopenia—Cyclosporine—systemic lupus erythematosus	0.000101	0.000972	CcSEcCtD
Penicillamine—Mental disorder—Hydrocortisone—systemic lupus erythematosus	0.000101	0.000971	CcSEcCtD
Penicillamine—Body temperature increased—Azathioprine—systemic lupus erythematosus	0.0001	0.000961	CcSEcCtD
Penicillamine—Haemoglobin—Betamethasone—systemic lupus erythematosus	9.91e-05	0.000952	CcSEcCtD
Penicillamine—Haemoglobin—Dexamethasone—systemic lupus erythematosus	9.91e-05	0.000952	CcSEcCtD
Penicillamine—Leukopenia—Mycophenolate mofetil—systemic lupus erythematosus	9.87e-05	0.000948	CcSEcCtD
Penicillamine—Haemorrhage—Betamethasone—systemic lupus erythematosus	9.86e-05	0.000947	CcSEcCtD
Penicillamine—Haemorrhage—Dexamethasone—systemic lupus erythematosus	9.86e-05	0.000947	CcSEcCtD
Penicillamine—Angiopathy—Methylprednisolone—systemic lupus erythematosus	9.84e-05	0.000945	CcSEcCtD
Penicillamine—Arthralgia—Cyclosporine—systemic lupus erythematosus	9.62e-05	0.000925	CcSEcCtD
Penicillamine—Anxiety—Cyclosporine—systemic lupus erythematosus	9.59e-05	0.000921	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—systemic lupus erythematosus	9.56e-05	0.000918	CcSEcCtD
Penicillamine—Mental disorder—Methylprednisolone—systemic lupus erythematosus	9.5e-05	0.000913	CcSEcCtD
Penicillamine—Urticaria—Leflunomide—systemic lupus erythematosus	9.5e-05	0.000912	CcSEcCtD
Penicillamine—Body temperature increased—Leflunomide—systemic lupus erythematosus	9.45e-05	0.000908	CcSEcCtD
Penicillamine—Arthralgia—Mycophenolate mofetil—systemic lupus erythematosus	9.39e-05	0.000902	CcSEcCtD
Penicillamine—Neuropathy peripheral—Prednisone—systemic lupus erythematosus	9.38e-05	0.000901	CcSEcCtD
Penicillamine—Anxiety—Mycophenolate mofetil—systemic lupus erythematosus	9.36e-05	0.000899	CcSEcCtD
Penicillamine—Toxic epidermal necrolysis—Methotrexate—systemic lupus erythematosus	9.34e-05	0.000897	CcSEcCtD
Penicillamine—Hypersensitivity—Azathioprine—systemic lupus erythematosus	9.33e-05	0.000896	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic lupus erythematosus	9.32e-05	0.000896	CcSEcCtD
Penicillamine—Dysgeusia—Triamcinolone—systemic lupus erythematosus	9.26e-05	0.00089	CcSEcCtD
Penicillamine—Thrombocytopenia—Cyclosporine—systemic lupus erythematosus	9.03e-05	0.000868	CcSEcCtD
Penicillamine—Asthma—Methotrexate—systemic lupus erythematosus	8.96e-05	0.000861	CcSEcCtD
Penicillamine—Skin disorder—Cyclosporine—systemic lupus erythematosus	8.96e-05	0.000861	CcSEcCtD
Penicillamine—Angiopathy—Dexamethasone—systemic lupus erythematosus	8.95e-05	0.000859	CcSEcCtD
Penicillamine—Angiopathy—Betamethasone—systemic lupus erythematosus	8.95e-05	0.000859	CcSEcCtD
Penicillamine—Eosinophilia—Methotrexate—systemic lupus erythematosus	8.88e-05	0.000853	CcSEcCtD
Penicillamine—Thrombocytopenia—Mycophenolate mofetil—systemic lupus erythematosus	8.81e-05	0.000847	CcSEcCtD
Penicillamine—Hypersensitivity—Leflunomide—systemic lupus erythematosus	8.81e-05	0.000846	CcSEcCtD
Penicillamine—Anorexia—Cyclosporine—systemic lupus erythematosus	8.79e-05	0.000845	CcSEcCtD
Penicillamine—Pancreatitis—Methotrexate—systemic lupus erythematosus	8.79e-05	0.000844	CcSEcCtD
Penicillamine—Skin disorder—Mycophenolate mofetil—systemic lupus erythematosus	8.74e-05	0.00084	CcSEcCtD
Penicillamine—Alopecia—Dexamethasone—systemic lupus erythematosus	8.71e-05	0.000837	CcSEcCtD
Penicillamine—Alopecia—Betamethasone—systemic lupus erythematosus	8.71e-05	0.000837	CcSEcCtD
Penicillamine—Diarrhoea—Azathioprine—systemic lupus erythematosus	8.66e-05	0.000832	CcSEcCtD
Penicillamine—Haemoglobin—Prednisone—systemic lupus erythematosus	8.63e-05	0.000829	CcSEcCtD
Penicillamine—Haemorrhage—Prednisone—systemic lupus erythematosus	8.59e-05	0.000825	CcSEcCtD
Penicillamine—Anorexia—Mycophenolate mofetil—systemic lupus erythematosus	8.58e-05	0.000824	CcSEcCtD
Penicillamine—Anxiety—Hydrocortisone—systemic lupus erythematosus	8.52e-05	0.000819	CcSEcCtD
Penicillamine—Pancytopenia—Methotrexate—systemic lupus erythematosus	8.51e-05	0.000818	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—systemic lupus erythematosus	8.49e-05	0.000816	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Cyclosporine—systemic lupus erythematosus	8.4e-05	0.000807	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Mycophenolate mofetil—systemic lupus erythematosus	8.2e-05	0.000788	CcSEcCtD
Penicillamine—Diarrhoea—Leflunomide—systemic lupus erythematosus	8.18e-05	0.000786	CcSEcCtD
Penicillamine—Vomiting—Azathioprine—systemic lupus erythematosus	8.05e-05	0.000773	CcSEcCtD
Penicillamine—Arthralgia—Methylprednisolone—systemic lupus erythematosus	8.04e-05	0.000772	CcSEcCtD
Penicillamine—Decreased appetite—Cyclosporine—systemic lupus erythematosus	8.02e-05	0.00077	CcSEcCtD
Penicillamine—Anxiety—Methylprednisolone—systemic lupus erythematosus	8.01e-05	0.000769	CcSEcCtD
Penicillamine—Rash—Azathioprine—systemic lupus erythematosus	7.98e-05	0.000767	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—systemic lupus erythematosus	7.98e-05	0.000767	CcSEcCtD
Penicillamine—Dermatitis—Azathioprine—systemic lupus erythematosus	7.97e-05	0.000766	CcSEcCtD
Penicillamine—Skin disorder—Hydrocortisone—systemic lupus erythematosus	7.96e-05	0.000765	CcSEcCtD
Penicillamine—Renal failure—Methotrexate—systemic lupus erythematosus	7.86e-05	0.000755	CcSEcCtD
Penicillamine—Decreased appetite—Mycophenolate mofetil—systemic lupus erythematosus	7.82e-05	0.000752	CcSEcCtD
Penicillamine—Anorexia—Hydrocortisone—systemic lupus erythematosus	7.82e-05	0.000751	CcSEcCtD
Penicillamine—Stomatitis—Methotrexate—systemic lupus erythematosus	7.79e-05	0.000749	CcSEcCtD
Penicillamine—Angiopathy—Prednisone—systemic lupus erythematosus	7.79e-05	0.000748	CcSEcCtD
Penicillamine—Haematuria—Methotrexate—systemic lupus erythematosus	7.62e-05	0.000732	CcSEcCtD
Penicillamine—Vomiting—Leflunomide—systemic lupus erythematosus	7.6e-05	0.00073	CcSEcCtD
Penicillamine—Alopecia—Prednisone—systemic lupus erythematosus	7.59e-05	0.000729	CcSEcCtD
Penicillamine—Hepatobiliary disease—Methotrexate—systemic lupus erythematosus	7.56e-05	0.000726	CcSEcCtD
Penicillamine—Rash—Leflunomide—systemic lupus erythematosus	7.54e-05	0.000724	CcSEcCtD
Penicillamine—Dermatitis—Leflunomide—systemic lupus erythematosus	7.53e-05	0.000723	CcSEcCtD
Penicillamine—Mental disorder—Prednisone—systemic lupus erythematosus	7.52e-05	0.000723	CcSEcCtD
Penicillamine—Nausea—Azathioprine—systemic lupus erythematosus	7.52e-05	0.000722	CcSEcCtD
Penicillamine—Skin disorder—Methylprednisolone—systemic lupus erythematosus	7.48e-05	0.000719	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Hydrocortisone—systemic lupus erythematosus	7.47e-05	0.000718	CcSEcCtD
Penicillamine—Agranulocytosis—Methotrexate—systemic lupus erythematosus	7.46e-05	0.000717	CcSEcCtD
Penicillamine—Urticaria—Cyclosporine—systemic lupus erythematosus	7.33e-05	0.000704	CcSEcCtD
Penicillamine—Body temperature increased—Cyclosporine—systemic lupus erythematosus	7.29e-05	0.000701	CcSEcCtD
Penicillamine—Anxiety—Dexamethasone—systemic lupus erythematosus	7.28e-05	0.0007	CcSEcCtD
Penicillamine—Anxiety—Betamethasone—systemic lupus erythematosus	7.28e-05	0.0007	CcSEcCtD
Penicillamine—Haemoglobin—Methotrexate—systemic lupus erythematosus	7.21e-05	0.000693	CcSEcCtD
Penicillamine—Haemorrhage—Methotrexate—systemic lupus erythematosus	7.18e-05	0.000689	CcSEcCtD
Penicillamine—Urticaria—Mycophenolate mofetil—systemic lupus erythematosus	7.15e-05	0.000687	CcSEcCtD
Penicillamine—Decreased appetite—Hydrocortisone—systemic lupus erythematosus	7.13e-05	0.000685	CcSEcCtD
Penicillamine—Body temperature increased—Mycophenolate mofetil—systemic lupus erythematosus	7.11e-05	0.000683	CcSEcCtD
Penicillamine—Nausea—Leflunomide—systemic lupus erythematosus	7.1e-05	0.000682	CcSEcCtD
Penicillamine—Urinary tract disorder—Methotrexate—systemic lupus erythematosus	7.09e-05	0.000681	CcSEcCtD
Penicillamine—Urethral disorder—Methotrexate—systemic lupus erythematosus	7.03e-05	0.000676	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Triamcinolone—systemic lupus erythematosus	7.03e-05	0.000676	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Methylprednisolone—systemic lupus erythematosus	7.02e-05	0.000674	CcSEcCtD
Penicillamine—Anaemia—Prednisone—systemic lupus erythematosus	6.91e-05	0.000664	CcSEcCtD
Penicillamine—Agitation—Prednisone—systemic lupus erythematosus	6.87e-05	0.00066	CcSEcCtD
Penicillamine—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	6.86e-05	0.000659	CcSEcCtD
Penicillamine—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	6.86e-05	0.000659	CcSEcCtD
Penicillamine—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	6.8e-05	0.000653	CcSEcCtD
Penicillamine—Tinnitus—Methotrexate—systemic lupus erythematosus	6.69e-05	0.000643	CcSEcCtD
Penicillamine—Anorexia—Betamethasone—systemic lupus erythematosus	6.68e-05	0.000641	CcSEcCtD
Penicillamine—Anorexia—Dexamethasone—systemic lupus erythematosus	6.68e-05	0.000641	CcSEcCtD
Penicillamine—Urticaria—Prednisolone—systemic lupus erythematosus	6.67e-05	0.000641	CcSEcCtD
Penicillamine—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	6.63e-05	0.000637	CcSEcCtD
Penicillamine—Urticaria—Hydrocortisone—systemic lupus erythematosus	6.51e-05	0.000626	CcSEcCtD
Penicillamine—Angiopathy—Methotrexate—systemic lupus erythematosus	6.51e-05	0.000625	CcSEcCtD
Penicillamine—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	6.48e-05	0.000623	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	6.38e-05	0.000613	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	6.38e-05	0.000613	CcSEcCtD
Penicillamine—Arthralgia—Prednisone—systemic lupus erythematosus	6.36e-05	0.000611	CcSEcCtD
Penicillamine—Anxiety—Prednisone—systemic lupus erythematosus	6.34e-05	0.000609	CcSEcCtD
Penicillamine—Alopecia—Methotrexate—systemic lupus erythematosus	6.34e-05	0.000609	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	6.32e-05	0.000607	CcSEcCtD
Penicillamine—Diarrhoea—Cyclosporine—systemic lupus erythematosus	6.31e-05	0.000606	CcSEcCtD
Penicillamine—Mental disorder—Methotrexate—systemic lupus erythematosus	6.29e-05	0.000604	CcSEcCtD
Penicillamine—Hypersensitivity—Prednisolone—systemic lupus erythematosus	6.18e-05	0.000594	CcSEcCtD
Penicillamine—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	6.16e-05	0.000592	CcSEcCtD
Penicillamine—Urticaria—Triamcinolone—systemic lupus erythematosus	6.13e-05	0.000589	CcSEcCtD
Penicillamine—Urticaria—Methylprednisolone—systemic lupus erythematosus	6.12e-05	0.000588	CcSEcCtD
Penicillamine—Dysgeusia—Methotrexate—systemic lupus erythematosus	6.12e-05	0.000588	CcSEcCtD
Penicillamine—Body temperature increased—Triamcinolone—systemic lupus erythematosus	6.1e-05	0.000586	CcSEcCtD
Penicillamine—Decreased appetite—Dexamethasone—systemic lupus erythematosus	6.09e-05	0.000585	CcSEcCtD
Penicillamine—Decreased appetite—Betamethasone—systemic lupus erythematosus	6.09e-05	0.000585	CcSEcCtD
Penicillamine—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	6.04e-05	0.00058	CcSEcCtD
Penicillamine—Skin disorder—Prednisone—systemic lupus erythematosus	5.93e-05	0.000569	CcSEcCtD
Penicillamine—Vomiting—Cyclosporine—systemic lupus erythematosus	5.87e-05	0.000564	CcSEcCtD
Penicillamine—Rash—Cyclosporine—systemic lupus erythematosus	5.82e-05	0.000559	CcSEcCtD
Penicillamine—Anorexia—Prednisone—systemic lupus erythematosus	5.81e-05	0.000559	CcSEcCtD
Penicillamine—Dermatitis—Cyclosporine—systemic lupus erythematosus	5.81e-05	0.000558	CcSEcCtD
Penicillamine—Anaemia—Methotrexate—systemic lupus erythematosus	5.77e-05	0.000555	CcSEcCtD
Penicillamine—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	5.72e-05	0.00055	CcSEcCtD
Penicillamine—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	5.69e-05	0.000546	CcSEcCtD
Penicillamine—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	5.68e-05	0.000545	CcSEcCtD
Penicillamine—Rash—Mycophenolate mofetil—systemic lupus erythematosus	5.67e-05	0.000545	CcSEcCtD
Penicillamine—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	5.67e-05	0.000545	CcSEcCtD
Penicillamine—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	5.61e-05	0.000539	CcSEcCtD
Penicillamine—Leukopenia—Methotrexate—systemic lupus erythematosus	5.59e-05	0.000537	CcSEcCtD
Penicillamine—Urticaria—Betamethasone—systemic lupus erythematosus	5.56e-05	0.000535	CcSEcCtD
Penicillamine—Urticaria—Dexamethasone—systemic lupus erythematosus	5.56e-05	0.000535	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	5.56e-05	0.000534	CcSEcCtD
Penicillamine—Body temperature increased—Betamethasone—systemic lupus erythematosus	5.54e-05	0.000532	CcSEcCtD
Penicillamine—Body temperature increased—Dexamethasone—systemic lupus erythematosus	5.54e-05	0.000532	CcSEcCtD
Penicillamine—Nausea—Cyclosporine—systemic lupus erythematosus	5.48e-05	0.000526	CcSEcCtD
Penicillamine—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	5.35e-05	0.000514	CcSEcCtD
Penicillamine—Arthralgia—Methotrexate—systemic lupus erythematosus	5.32e-05	0.000511	CcSEcCtD
Penicillamine—Decreased appetite—Prednisone—systemic lupus erythematosus	5.3e-05	0.000509	CcSEcCtD
Penicillamine—Rash—Prednisolone—systemic lupus erythematosus	5.29e-05	0.000509	CcSEcCtD
Penicillamine—Dermatitis—Prednisolone—systemic lupus erythematosus	5.29e-05	0.000508	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	5.28e-05	0.000507	CcSEcCtD
Penicillamine—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	5.27e-05	0.000506	CcSEcCtD
Penicillamine—Vomiting—Hydrocortisone—systemic lupus erythematosus	5.21e-05	0.000501	CcSEcCtD
Penicillamine—Rash—Hydrocortisone—systemic lupus erythematosus	5.17e-05	0.000497	CcSEcCtD
Penicillamine—Dermatitis—Hydrocortisone—systemic lupus erythematosus	5.16e-05	0.000496	CcSEcCtD
Penicillamine—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	4.99e-05	0.00048	CcSEcCtD
Penicillamine—Nausea—Prednisolone—systemic lupus erythematosus	4.99e-05	0.000479	CcSEcCtD
Penicillamine—Skin disorder—Methotrexate—systemic lupus erythematosus	4.95e-05	0.000476	CcSEcCtD
Penicillamine—Vomiting—Triamcinolone—systemic lupus erythematosus	4.91e-05	0.000472	CcSEcCtD
Penicillamine—Vomiting—Methylprednisolone—systemic lupus erythematosus	4.9e-05	0.000471	CcSEcCtD
Penicillamine—Nausea—Hydrocortisone—systemic lupus erythematosus	4.87e-05	0.000468	CcSEcCtD
Penicillamine—Rash—Triamcinolone—systemic lupus erythematosus	4.87e-05	0.000468	CcSEcCtD
Penicillamine—Dermatitis—Triamcinolone—systemic lupus erythematosus	4.86e-05	0.000467	CcSEcCtD
Penicillamine—Anorexia—Methotrexate—systemic lupus erythematosus	4.86e-05	0.000467	CcSEcCtD
Penicillamine—Rash—Methylprednisolone—systemic lupus erythematosus	4.86e-05	0.000467	CcSEcCtD
Penicillamine—Dermatitis—Methylprednisolone—systemic lupus erythematosus	4.85e-05	0.000466	CcSEcCtD
Penicillamine—Urticaria—Prednisone—systemic lupus erythematosus	4.85e-05	0.000466	CcSEcCtD
Penicillamine—Body temperature increased—Prednisone—systemic lupus erythematosus	4.82e-05	0.000463	CcSEcCtD
Penicillamine—Diarrhoea—Dexamethasone—systemic lupus erythematosus	4.79e-05	0.00046	CcSEcCtD
Penicillamine—Diarrhoea—Betamethasone—systemic lupus erythematosus	4.79e-05	0.00046	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	4.64e-05	0.000446	CcSEcCtD
Penicillamine—Nausea—Triamcinolone—systemic lupus erythematosus	4.59e-05	0.000441	CcSEcCtD
Penicillamine—Nausea—Methylprednisolone—systemic lupus erythematosus	4.58e-05	0.00044	CcSEcCtD
Penicillamine—Hypersensitivity—Prednisone—systemic lupus erythematosus	4.49e-05	0.000432	CcSEcCtD
Penicillamine—Vomiting—Betamethasone—systemic lupus erythematosus	4.45e-05	0.000428	CcSEcCtD
Penicillamine—Vomiting—Dexamethasone—systemic lupus erythematosus	4.45e-05	0.000428	CcSEcCtD
Penicillamine—Decreased appetite—Methotrexate—systemic lupus erythematosus	4.43e-05	0.000426	CcSEcCtD
Penicillamine—Rash—Dexamethasone—systemic lupus erythematosus	4.42e-05	0.000424	CcSEcCtD
Penicillamine—Rash—Betamethasone—systemic lupus erythematosus	4.42e-05	0.000424	CcSEcCtD
Penicillamine—Dermatitis—Dexamethasone—systemic lupus erythematosus	4.41e-05	0.000424	CcSEcCtD
Penicillamine—Dermatitis—Betamethasone—systemic lupus erythematosus	4.41e-05	0.000424	CcSEcCtD
Penicillamine—Diarrhoea—Prednisone—systemic lupus erythematosus	4.17e-05	0.000401	CcSEcCtD
Penicillamine—Nausea—Dexamethasone—systemic lupus erythematosus	4.16e-05	0.0004	CcSEcCtD
Penicillamine—Nausea—Betamethasone—systemic lupus erythematosus	4.16e-05	0.0004	CcSEcCtD
Penicillamine—Urticaria—Methotrexate—systemic lupus erythematosus	4.05e-05	0.000389	CcSEcCtD
Penicillamine—Body temperature increased—Methotrexate—systemic lupus erythematosus	4.03e-05	0.000387	CcSEcCtD
Penicillamine—Vomiting—Prednisone—systemic lupus erythematosus	3.88e-05	0.000373	CcSEcCtD
Penicillamine—Rash—Prednisone—systemic lupus erythematosus	3.85e-05	0.00037	CcSEcCtD
Penicillamine—Dermatitis—Prednisone—systemic lupus erythematosus	3.84e-05	0.000369	CcSEcCtD
Penicillamine—Hypersensitivity—Methotrexate—systemic lupus erythematosus	3.76e-05	0.000361	CcSEcCtD
Penicillamine—Nausea—Prednisone—systemic lupus erythematosus	3.62e-05	0.000348	CcSEcCtD
Penicillamine—Diarrhoea—Methotrexate—systemic lupus erythematosus	3.49e-05	0.000335	CcSEcCtD
Penicillamine—Vomiting—Methotrexate—systemic lupus erythematosus	3.24e-05	0.000311	CcSEcCtD
Penicillamine—Rash—Methotrexate—systemic lupus erythematosus	3.21e-05	0.000309	CcSEcCtD
Penicillamine—Dermatitis—Methotrexate—systemic lupus erythematosus	3.21e-05	0.000309	CcSEcCtD
Penicillamine—Nausea—Methotrexate—systemic lupus erythematosus	3.03e-05	0.000291	CcSEcCtD
